Treatment News : Preventive Therapy Lowers TB Deaths in People With HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » August 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


August 20, 2013

Preventive Therapy Lowers TB Deaths in People With HIV

Isoniazid preventive therapy (IPT) for tuberculosis greatly reduces the risk that people with HIV will develop TB or die of the disease, which is the leading cause of death among the HIV population in developing nations with the greatest rates of HIV. A team of researchers from Johns Hopkins University and Brazil studied 12,816 people with HIV in that South American country, all of whom were eligible for screening for TB infection or active TB disease, but had no symptoms of the disease and could begin taking the antibiotic isoniazid daily for six months. About 1,186 of these participants tested positive for TB infection at the study’s baseline, but they had no symptoms and were thus eligible for IPT therapy.

During the four-year study, there were 838 deaths and 475 people developed TB. The investigators found that IPT lowered TB deaths and new cases of active TB disease by 31 percent; alone, new cases of TB dropped by 13 percent.

Restricting their analysis to the 12,196 participants who made it to at least one annual checkup appointment, the investigators found that IPT lowered the death rate and number of new TB cases by 55 percent. The number of active TB cases fell by 58 percent.

To read a release about the study, click here.

To read the study abstract, click here.

Search: isoniazid preventive therapy, IPT, Johns Hopkins, tuberculosis, HIV, TB.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.